E Mayayo

CYP2A6: genetics, structure, regulation, and function

Normal Volumetric Bone Mineral Density and Bone Turnover in Young Men with Histories of Constitutional Delay of Puberty

Sex Differences in the Expression of Hepatic Drug Metabolizing Enzymes

Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer

Reliability and construct validity of the compatible MRI scoring system for evaluation of elbows in haemophilic children

Chronic kidney disease

Nitric oxide deficiency in chronic kidney disease

Sonography for assessment of haemophilic arthropathy in children: a systematic protocol

A review of airborne polycyclic aromatic hydrocarbons (PAHs) and their human health effects

Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation

Plasma Letrozole Concentrations in Postmenopausal Women With Breast Cancer Are Associated With CYP2A6 Genetic Variants, Body Mass Index, and Age

Arginine metabolism and nutrition in growth, health and disease

Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline

Intrinsic Sexually Dimorphic Expression of the Principal Human CYP3A4 Correlated with Suboptimal Activation of GH/Glucocorticoid-Dependent Transcriptional Pathways in Men

Guidelines for the management of hemophilia

Lack of effect of growth hormone replacement therapy on CYP1A2 and xanthine oxidase activities in growth hormone–deficient children

Value of magnetic resonance imaging for the diagnosis and follow‐up of haemophilic arthropathy

Constitutional delay in growth and puberty: a comparison of final height achieved between treated and untreated children.

CYP2A6 activity in a healthy Spanish population: effect of age, sex, smoking, and oral contraceptives

Effects of growth hormone deficiency and rhGH replacement therapy on the 6?-hydroxycortisol/free cortisol ratio, a marker of CYP3A activity, in growth hormone-deficient children

Five caffeine metabolite ratios to measure tobacco-induced CYP1A2 activity and their relationships with urinary mutagenicity and urine flow.